论文部分内容阅读
一、降脂药物的治疗指征降脂药物的使用指征,目前尚无一致的意见。一般认为,当血浆总胆固醇达200～240mg/dl、低密度脂蛋白(LDL)胆固醇达130～160mg/dl时,为临界增高;当总胆周醇≥240mg/dl和LDL胆固醇≥160mg/dl时,为胆固醇增高;甘油三酯(TG)达250～500mg/dl时为轻度增高,≥500mg/dl为重度增高。对高脂血症患者是否采用药物治疗,除参考血脂浓度外,还要考虑是否有冠心病的其他易患因素。对患有冠心病或具有2项以上冠心病易患因
First, the treatment of lipid-lowering drugs indications for the use of lipid-lowering drugs, there is no consensus. Is generally believed that when the total plasma cholesterol reached 200 ~ 240mg / dl, low-density lipoprotein (LDL) cholesterol 130 ~ 160mg / dl, the critical increase; when the total cholesterol week ≥ 240mg / dl and LDL cholesterol ≥ 160mg / dl When the cholesterol increased; triglyceride (TG) up to 250 ~ 500mg / dl was mildly increased, ≥ 500mg / dl was increased significantly. For patients with hyperlipidemia whether drug therapy, in addition to the reference lipid concentration, but also to consider whether there are other risk factors for coronary heart disease. For patients with coronary heart disease or more than 2 coronary heart disease due to